Several studies have proved that the overexpression of SREBP-1c, FAS, and ACC is associated with accelerated hepatic lipogenesis in NAFLD animal models [41,42], while downregulated mRNA expression of these genes can protect development of liver steatosis [43,44]. The gene discussed is FAS; the disease is metabolic dysfunction-associated steatotic liver disease.